A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF- 1 in the development of myelofibrosis
about
The secret life of a megakaryocyte: emerging roles in bone marrow homeostasis controlNonclinical safety assessment of a synthetic peptide thrombopoietin agonist: effects on platelets, bone homeostasis, and immunogenicity and the implications for clinical safety monitoring of adverse bone effects.Repercussion of Megakaryocyte-Specific Gata1 Loss on Megakaryopoiesis and the Hematopoietic Precursor Compartment.Pathological interactions between hematopoietic stem cells and their niche revealed by mouse models of primary myelofibrosis.In vitro megakaryocyte differentiation and proplatelet formation in Ph-negative classical myeloproliferative neoplasms: distinct patterns in the different clinical phenotypes.Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase.Role of thrombopoietin in mast cell differentiation.The role of Smad signaling in hematopoiesis and translational hematology.Preclinical models for drug selection in myeloproliferative neoplasms.An immune dysregulation in MPN.Immunological Consequences of JAK Inhibition: Friend or Foe?The role of the extracellular matrix in primary myelofibrosis.The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms.Thrombopoietin/TGF-β1 Loop Regulates Megakaryocyte Extracellular Matrix Component Synthesis.Anti-transforming growth factor-β therapy in patients with myelofibrosis.
P2860
Q28082685-D932600C-A12E-4205-B77D-A1FAD2CC95A9Q33396650-CFEE03B3-CAE1-4AFC-9F24-42CB06B14ACAQ33432035-76FF6549-3ACA-4D88-BD74-70460FF39B3BQ33753094-F23FF2F3-D358-43DD-A9B9-B72ADA500443Q33941304-8FDFCF07-F79B-4645-A006-2B4F60DEB65CQ35144992-89FF4BBC-FF2A-4361-A18A-AA0036EF9951Q36806176-18820395-513E-42D9-98EF-D15B5011F084Q37874928-D753A3B2-F8D5-4C4F-A387-1AA2456B30A7Q38154517-8F11C11D-1DC2-40FD-A68B-06654EB78134Q38241495-542F9C7E-3B9B-41F8-B00C-CEA892F3BF3CQ38570383-FCBABA07-22F0-45C9-8FC3-F3BBAE63E7CBQ39117766-009CA02F-EDFA-4FAD-BF68-37D3B340B70BQ39451293-CCAB0035-DEA1-4F00-BF1A-5283C1195F46Q40126127-1F140CA5-4ED4-4610-BB31-38E2F4788C9FQ50986633-A2EB515A-F046-4E38-A281-38D05FB9555F
P2860
A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF- 1 in the development of myelofibrosis
description
article
@en
im Mai 2005 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2005
@uk
name
A pathobiologic pathway linkin ...... e development of myelofibrosis
@en
A pathobiologic pathway linkin ...... e development of myelofibrosis
@nl
type
label
A pathobiologic pathway linkin ...... e development of myelofibrosis
@en
A pathobiologic pathway linkin ...... e development of myelofibrosis
@nl
prefLabel
A pathobiologic pathway linkin ...... e development of myelofibrosis
@en
A pathobiologic pathway linkin ...... e development of myelofibrosis
@nl
P2093
P50
P1433
P1476
A pathobiologic pathway linkin ...... e development of myelofibrosis
@en
P2093
Alessandro M Vannucchi
Anna Rita Migliaccio
Elena Alfani
Eugenio Torre
Francesco Paoletti
Giovanni Migliaccio
Lucia Bianchi
Mitsuo Nishikawa
Rodolfo Lorenzini
Rosa Alba Rana
P304
P356
10.1182/BLOOD-2004-04-1320
P407
P577
2005-01-21T00:00:00Z